Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR)

CUSIP: 12233L107

Q3 2024 13F Holders as of 30 Sep 2024

Security type / class
Equity / American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share
Total 13F shares
21,212
Total 13F value
$64,484
Holder snapshot 5 signals
Share change
-885
SEC-reported price per share
$3.04
Number of holders
1
Value change
-$761
Number of sells
1
Security identity 1 source field
Shares outstanding
9,036,176

Security key

12233L107

Report period

Q3 2024

Institutions

1

Top holders

1

BNR full security history Ownership snapshot Full 13F holder table Newer quarter: Q4 2024 Previous quarter: Q2 2024 Burning Rock Biotech Ltd SEC filings Burning Rock Biotech Ltd company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of BNR - Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Kynam Capital Management, LP
Disclosed value leader
Kynam Capital Management, LP
Comparable rows
15/15
Latest evidence
30 Jun 2024
13F Lead comparable stake: 11% Showing 1-6 of 15 holder rows.

Quick read

Kynam Capital Management, LP leads the comparable SEC ownership view at 11%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Comparable ownership Top 5
Kynam Capital Management, LP 11%
MASSACHUSETTS FINANCIAL SERVICES ... 4.4%
FIL Ltd 3.2%
MILLENNIUM MANAGEMENT LLC 1.9%
Sumitomo Mitsui Trust Group, Inc. 0.64%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Kynam Capital Management, LP
13F
Company
13F
11%
$6,283,880
974,668 shares
 — 30 Jun 2024
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
13F
Company
13F
4.4%
$2,522,145
391,200 shares
 — 30 Jun 2024
FIL Ltd
13F
Company
13F
3.2%
$1,766,848
280,898 shares
 — 30 Jun 2024
MILLENNIUM MANAGEMENT LLC
13F
Company
13F
1.9%
$1,080,905
171,845 shares
 — 30 Jun 2024
Sumitomo Mitsui Trust Group, Inc.
13F
Company
13F
0.64%
$362,629
56,246 shares
 — 30 Jun 2024
Amova Asset Management Americas, Inc.
13F
Company
13F
0.64%
$353,787
56,246 shares
 — 30 Jun 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
1
Shares
21,212
Rows available
1
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders
2
Q3 2024 holders
1
Holder diff
-1
Investor Q2 2024 Shares Q3 2024 Shares Share Diff Share Chg % Q2 2024 value Q3 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .